ACI Stock Analysis: Albertsons Companies | NYSE
Grocery Stores | NYSE, USA | Market Cap: 6.377m USD | 12M Return: -23.5% | US0130911037 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 110M
EPS Trend: -96.3%
Qual. Beats: 0
Rev. Trend: 97.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 6.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Albertsons Companies, Inc. (NYSE: ACI) is a U.S. food and drug retailer headquartered in Boise, Idaho, founded in 1860 and taken public in June 2020. It sells groceries, general merchandise, health and beauty products, pharmacy items, vaccines, and fuel, and operates in-store pharmacies, branded coffee shops, fuel centers, distribution centers, and manufacturing facilities, as well as digital platforms. The company runs a multi-banner strategy with regional brands such as Safeway, Vons, Jewel-Osco, ACME, Shaws, Tom Thumb, and Haggen, alongside the flagship Albertsons banner.
As a Food Retail operator in the Consumer Staples sector, Albertsons competes in a mature, highly fragmented industry characterized by thin margins, where scale, private-label penetration, and integrated supply chains are the primary levers for profitability. Its combination of grocery, pharmacy, and fuel under one roof reflects the typical one-stop format used by large U.S. supermarket chains to drive store traffic and basket size.
- Kroger merger blocked, $4.7B termination fee boosts cash position
- Private label brands expand grocery margins amid food inflation
- Pharmacy and fuel centers deliver high-margin recurring revenue
| Net Income: -51.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.53 > 1.0 |
| NWC/Revenue: -1.91% < 20% (prev -1.92%; Δ 0.01% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.60b > Net Income -51.3m |
| Net Debt (22.2b) to EBITDA (3.14b): 7.06 < 3 |
| Current Ratio: 0.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (488.2m) vs 12m ago -13.21% < -2% |
| Gross Margin: 26.99% > 18% (prev 27.33%; Δ -0.34% > 0.5%) |
| Asset Turnover: 307.8% > 50% (prev 303.1%; Δ 4.72% > 0%) |
| Interest Coverage Ratio: 0.84 > 6 (EBIT TTM 461.9m / Interest Expense TTM 548.8m) |
| A: -0.06 (Total Current Assets 7.06b - Total Current Liabilities 8.65b) / Total Assets 27.2b |
| B: 0.05 (Retained Earnings 1.35b / Total Assets 27.2b) |
| C: 0.02 (EBIT TTM 461.9m / Avg Total Assets 27.0b) |
| D: 0.06 (Book Value of Equity 1.43b / Total Liabilities 25.8b) |
| Altman-Z'' = -0.05 = B |
| DSRI: 1.08 (Receivables 1.07b/968.8m, Revenue 83.2b/81.4b) |
| GMI: 1.01 (GM 27.33% / 26.99%) |
| AQI: 0.92 (AQ_t 0.14 / AQ_t-1 0.15) |
| SGI: 1.02 (Revenue 83.2b / 81.4b) |
| TATA: -0.10 (NI -51.3m - CFO 2.60b) / TA 27.2b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 28, 2026, the stock is trading at USD 13.72 with a total of 10,936,884 shares traded. Over the past week, the price has changed by +3.12%, over one month by +19.33%, over three months by +22.17% and over the past year by -23.49%.
Current recommended Stop Loss: 12.80 (which is 6.7% or 2.1 ATR below the current price).
Albertsons Companies has received a consensus analysts rating of 3.16. Therefore, it is recommended to hold ACI.
- StrongBuy: 3
- Buy: 1
- Hold: 12
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 14.1 | 2.5% |
P/E Forward = 6.0938
P/S = 0.0766
P/B = 3.521
P/EG = 1.2188
Revenue TTM = 83.2b USD
EBIT TTM = 461.9m USD
EBITDA TTM = 3.14b USD
Long Term Debt = 8.41b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 22.5b USD (from shortLongTermDebtTotal, last quarter) + Leases 6.54b
Net Debt = 22.2b USD (calculated: Debt 22.5b - CCE 282.0m)
Enterprise Value = 28.6b USD (6.38b + Debt 22.5b - CCE 282.0m)
Interest Coverage Ratio = 0.84 (Ebit TTM 461.9m / Interest Expense TTM 548.8m)
EV/FCF = 35.16x (Enterprise Value 28.6b / FCF TTM 811.9m)
FCF Yield = 2.84% (FCF TTM 811.9m / Enterprise Value 28.6b)
FCF Margin = 0.98% (FCF TTM 811.9m / Revenue TTM 83.2b)
Net Margin = -0.06% (Net Income TTM -51.3m / Revenue TTM 83.2b)
Gross Margin = 26.99% ((Revenue TTM 83.2b - Cost of Revenue TTM 60.8b) / Revenue TTM)
Gross Margin QoQ = 26.76% (prev 26.61%)
Tobins Q-Ratio = 1.05 (Enterprise Value 28.6b / Total Assets 27.2b)
Interest Expense / Debt = 2.44% (Interest Expense 548.8m / Debt 22.5b)
Taxrate = 17.86% (11.2m / 62.7m)
NOPAT = 379.4m (EBIT 461.9m * (1 - 17.86%))
Current Ratio = 0.82 (Total Current Assets 7.06b / Total Current Liabilities 8.65b)
Debt / Equity = 15.67 (Debt 22.5b / totalStockholderEquity, last quarter 1.43b)
Debt / EBITDA = 7.06 (Net Debt 22.2b / EBITDA 3.14b)
Debt / FCF = 27.31 (Net Debt 22.2b / FCF TTM 811.9m)
Total Stockholder Equity = 1.85b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.19% (Net Income -51.3m / Total Assets 27.2b)
RoE = -2.78% (Net Income TTM -51.3m / Total Stockholder Equity 1.85b)
RoCE = 4.50% (EBIT 461.9m / Capital Employed (Equity 1.85b + L.T.Debt 8.41b))
RoIC = 1.91% (NOPAT 379.4m / Invested Capital 19.9b)
WACC = 2.61% (E(6.38b)/V(28.8b) * Re(4.75%) + D(22.5b)/V(28.8b) * Rd(2.44%) * (1-Tc(0.18)))
Discount Rate = 4.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.06 | Cagr: -7.46%
[DCF] Terminal Value 77.97% ; FCFF base≈750.8m ; Y1≈860.6m ; Y5≈1.27b
[DCF] Fair Price = N/A (negative equity: EV 19.1b - Net Debt 22.2b = -3.11b; debt exceeds intrinsic value)
EPS Correlation: -96.31 | EPS CAGR: -14.37% | SUE: 0.43 | # QB: 0
Revenue Correlation: 97.37 | Revenue CAGR: 2.12% | SUE: 0.25 | # QB: 0
EPS current Quarter (2026-11-30): EPS=0.62 | Chg30d=-4.82% | Revisions=-25% | Analysts=17
EPS current Year (2027-02-28): EPS=1.75 | Chg30d=-2.18% | Revisions=-25% | GrowthEPS=-19.6% | GrowthRev=-1.6%
EPS next Year (2028-02-29): EPS=1.70 | Chg30d=-8.21% | Revisions=+25% | GrowthEPS=-3.2% | GrowthRev=+0.5%
[Analyst] Revisions Ratio: -17% (up=1, down=2)